These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20195680)

  • 1. The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study.
    Ohno H; Mizumoto C; Otsuki Y; Oguma S; Yoshida Y
    Int J Clin Oncol; 2010 Apr; 15(2):172-8. PubMed ID: 20195680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
    Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
    Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable subcutaneous infusion ports.
    Soh LT; Ang PT
    Support Care Cancer; 1993 Mar; 1(2):108-10. PubMed ID: 8143103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of infections and complications in central venous catheters in adults with solid tumours.
    Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
    J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Neutropenia at the Time of Implantable Subcutaneous Chest Port Insertion Is Not a Risk Factor for Port Removal at a Tertiary Pediatric Center.
    Hoss DR; Bedros AA; Mesipam A; Criddle J; Smith JC
    J Vasc Interv Radiol; 2017 Mar; 28(3):398-402. PubMed ID: 28034702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
    Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D
    Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients.
    Devrim İ; Oruç Y; Demirağ B; Kara A; Düzgöl M; Uslu S; Yaşar N; Aydın Köker S; Töret E; Bayram N; Vergin C
    J Vasc Access; 2018 Jul; 19(4):358-365. PubMed ID: 29926785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retained catheter: a rare complication associated with totally implantable venous ports.
    Nishinari K; Bernardi CV; Wolosker N; Yazbek G
    J Vasc Access; 2010; 11(2):159-61. PubMed ID: 20119912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-lumen central venous port catheters: simultaneous application for chemotherapy and parenteral nutrition in cancer patients.
    Teichgräber UK; Nagel SN; Kausche S; Streitparth F; Cho CH
    J Vasc Access; 2010; 11(4):335-41. PubMed ID: 20954131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally implantable ports connected to valved catheters for chemotherapy: experience from 350 Groshong devices.
    Nishinari K; Wolosker N; Bernardi CV; Yazbek G
    J Vasc Access; 2010; 11(1):17-22. PubMed ID: 20119917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
    Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of radiologically implanted central venous port systems explanted due to complications.
    Teichgräber UK; Kausche S; Nagel SN
    J Vasc Access; 2011; 12(4):306-12. PubMed ID: 21534232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Predictors of Port Infections in Adult Patients with Hematologic Malignancies.
    Zhang S; Kobayashi K; Faridnia M; Skummer P; Zhang D; Karmel MI
    J Vasc Interv Radiol; 2018 Aug; 29(8):1148-1155. PubMed ID: 29960670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.
    Biffi R; De Braud F; Orsi F; Pozzi S; Arnaldi P; Goldhirsch A; Rotmensz N; Robertson C; Bellomi M; Andreoni B
    Cancer; 2001 Sep; 92(5):1204-12. PubMed ID: 11571734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial.
    Biffi R; Orsi F; Pozzi S; Pace U; Bonomo G; Monfardini L; Della Vigna P; Rotmensz N; Radice D; Zampino MG; Fazio N; de Braud F; Andreoni B; Goldhirsch A
    Ann Oncol; 2009 May; 20(5):935-40. PubMed ID: 19179550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report.
    Solinas G; Platini F; Trivellato M; Rigo C; Alabiso O; Galetto AS
    J Vasc Access; 2017 Jul; 18(4):325-327. PubMed ID: 28665463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.